Corrigendum to “Strong response to first-line osimertinib and chemotherapy in EGFR L861Q-mutant NSCLC: a case report” [Current Problems in Cancer: Case Reports 23 (2026), Article 100431]

Current Problems in Cancer: Case Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles